PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.95%
Revenue growth above 1.5x BRZE's 1.03%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.67%
Gross profit growth above 1.5x BRZE's 0.10%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-93.99%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-80.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-97.47%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-101.01%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-101.01%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.72%
Share reduction more than 1.5x BRZE's 1.61%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.72%
Diluted share reduction more than 1.5x BRZE's 1.61%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-2.32%
Negative OCF growth while BRZE is at 41.33%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-5.81%
Negative FCF growth while BRZE is at 50.42%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
71.47%
Positive 10Y revenue/share CAGR while BRZE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
71.47%
Positive 5Y CAGR while BRZE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
129.82%
3Y revenue/share CAGR above 1.5x BRZE's 86.48%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
158.19%
10Y OCF/share CAGR under 50% of BRZE's 3655.42%. Michael Burry would worry about a persistent underperformance in cash creation.
158.19%
Below 50% of BRZE's 3655.42%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
196.37%
3Y OCF/share CAGR above 1.5x BRZE's 20.14%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
76.40%
Net income/share CAGR above 1.5x BRZE's 6.04% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
76.40%
5Y net income/share CAGR above 1.5x BRZE's 6.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
72.16%
3Y net income/share CAGR above 1.5x BRZE's 19.48%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
11.07%
Positive growth while BRZE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
11.07%
Positive 5Y equity/share CAGR while BRZE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
4.69%
Positive short-term equity growth while BRZE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.50%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.65%
Inventory is declining while BRZE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.44%
Asset growth 1.25-1.5x BRZE's 2.08%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
4.71%
Positive BV/share change while BRZE is negative. John Neff sees a clear edge over a competitor losing equity.
2.27%
We have some new debt while BRZE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
13.60%
R&D growth drastically higher vs. BRZE's 9.51%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
11.38%
SG&A growth well above BRZE's 15.73%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.